» Articles » PMID: 18299317

On the Pathogenicity of Autoantigen-specific T-cell Receptors

Overview
Journal Diabetes
Specialty Endocrinology
Date 2008 Feb 27
PMID 18299317
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Type 1 diabetes is mediated by T-cell entry into pancreatic islets and destruction of insulin-producing beta-cells. The relative contribution of T-cells specific for different autoantigens is largely unknown because relatively few have been assessed in vivo.

Research Design And Methods: We generated mice possessing a monoclonal population of T-cells expressing 1 of 17 T-cell receptors (TCR) specific for either known autoantigens (GAD65, insulinoma-associated protein 2 (IA2), IA2beta/phogrin, and insulin), unknown islet antigens, or control antigens on a NOD.scid background using retroviral-mediated stem cell gene transfer and 2A-linked multicistronic retroviral vectors (referred to herein as retrogenic [Rg] mice). The TCR Rg approach provides a mechanism by which T-cells with broad phenotypic differences can be directly compared.

Results: Neither GAD- nor IA2-specific TCRs mediated T-cell islet infiltration or diabetes even though T-cells developed in these Rg mice and responded to their cognate epitope. IA2beta/phogrin and insulin-specific Rg T-cells produced variable levels of insulitis, with one TCR producing delayed diabetes. Three TCRs specific for unknown islet antigens produced a hierarchy of insulitogenic and diabetogenic potential (BDC-2.5 > NY4.1 > BDC-6.9), while a fourth (BDC-10.1) mediated dramatically accelerated disease, with all mice diabetic by day 33, well before full T-cell reconstitution (days 42-56). Remarkably, as few as 1,000 BDC-10.1 Rg T-cells caused rapid diabetes following adoptive transfer into NOD.scid mice. CONCLUSIONS; Our data show that relatively few autoantigen-specific TCRs can mediate islet infiltration and beta-cell destruction on their own and that autoreactivity does not necessarily imply pathogenicity.

Citing Articles

Antigen-specific T cell responses in autoimmune diabetes.

Dwyer A, Shaheen Z, Fife B Front Immunol. 2024; 15:1440045.

PMID: 39211046 PMC: 11358097. DOI: 10.3389/fimmu.2024.1440045.


The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.

Groegler J, Callebaut A, James E, Delong T Diabetologia. 2024; 67(8):1507-1516.

PMID: 38811417 DOI: 10.1007/s00125-024-06164-x.


Aire mediates tolerance to insulin through thymic trimming of high-affinity T cell clones.

Smith J, Yuen B, Purtha W, Balolong J, Phipps J, Crawford F Proc Natl Acad Sci U S A. 2024; 121(20):e2320268121.

PMID: 38709934 PMC: 11098115. DOI: 10.1073/pnas.2320268121.


The immunology of type 1 diabetes.

Herold K, Delong T, Perdigoto A, Biru N, Brusko T, Walker L Nat Rev Immunol. 2024; 24(6):435-451.

PMID: 38308004 PMC: 7616056. DOI: 10.1038/s41577-023-00985-4.


Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice.

Spanier J, Fung V, Wardell C, Alkhatib M, Chen Y, Swanson L J Clin Invest. 2023; 133(18).

PMID: 37561596 PMC: 10503798. DOI: 10.1172/JCI168601.